LivaNova PLC (LIVN) — SEC Filings

Latest SEC filings for LivaNova PLC (LIVN), explained in plain English.

Sentiment Overview: 1 bullish, 1 bearish, 29 neutral

Recent Filings (31)

• LivaNova Swings to $273M Loss on Environmental Charge, Revenue Up 10% — 10-Q · 2025-11-05T00:00:00.000Z [bearish] Risk: high
  LivaNova PLC reported a significant net loss of $273.377 million for the nine months ended September 30, 2025, a stark contrast to the net income of $7.343 mill
• LivaNova PLC: Director Departs, New Officers Elected — 8-K · 2025-09-04T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC announced on September 3, 2025, the departure of Director Patrick J. Lynch. The company also reported on the election of new directors and the appo
• LivaNova PLC Files 8-K on Operations and Financials — 8-K · 2025-08-06T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on August 6, 2025, to report on its results of operations and financial condition, as well as to file financial statements and exhibit
• 8-K Filing — 8-K · 2025-06-11T00:00:00.000Z [neutral]
• LivaNova PLC Files 8-K: Regulation FD Disclosure — 8-K · 2025-05-21T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC filed an 8-K on May 21, 2025, reporting an event on May 15, 2025. The filing is a Regulation FD Disclosure, indicating it contains material non-pub
• LivaNova PLC Files Q1 2025 10-Q, Discloses Litigation — 10-Q · 2025-05-07T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC filed a 10-Q for the period ending March 31, 2025. The company reported on its financial performance and disclosed ongoing litigation, including a
• LivaNova PLC Files Definitive Proxy Statement — DEF 14A · 2025-04-30T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 11, 2025. The filing, designated as DEF 14A, outlines the co
• LivaNova PLC Files 8-K for Regulation FD Disclosure — 8-K · 2025-03-17T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on March 17, 2025, reporting an event on March 14, 2025. The filing is related to Regulation FD Disclosure. The company is incorporate
• 10-K Filing — 10-K · 2025-02-25T00:00:00.000Z [neutral]
• LivaNova PLC Files 8-K with Regulatory Updates — 8-K · 2024-11-01T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on November 1, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's prin
• LivaNova PLC 10-Q: Litigation and Restructuring Update — 10-Q · 2024-10-31T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC filed a 10-Q for the period ending September 30, 2024. The filing indicates a pending litigation matter related to CyberLitigation, with a minimum
• LivaNova PLC Files 8-K on Financials — 8-K · 2024-10-30T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on October 30, 2024, reporting on its financial condition and results of operations. The filing includes financial statements and exhi
• LivaNova PLC Reports Board Changes and Executive Compensation Updates — 8-K · 2024-10-08T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC announced on October 8, 2024, changes in its board of directors and executive compensation arrangements. The filing details the departure of certai
• LivaNova PLC Announces Board and Officer Changes — 8-K · 2024-09-10T00:00:00.000Z [neutral] Risk: low
  On September 10, 2024, LivaNova PLC filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on t
• LivaNova PLC Files 10-Q, Details Restructuring Plan — 10-Q · 2024-08-01T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC filed a 10-Q for the period ending June 30, 2024. The filing details financial performance and includes information on a restructuring plan, with s
• LivaNova PLC Files 8-K on Financials — 8-K · 2024-07-31T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on July 31, 2024, reporting on its results of operations and financial condition, and including financial statements and exhibits. The
• LivaNova PLC Files 8-K: Board Changes and Compensation Details — 8-K · 2024-06-12T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC announced on June 11, 2024, changes in its board of directors and executive compensation arrangements. The filing also includes information regardi
• LivaNova PLC Files Definitive Proxy Statement — DEFA14A · 2024-06-06T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed a Definitive Proxy Statement (DEFA14A) on June 6, 2024. This filing is related to the company's annual shareholder meeting and the solicitati
• LivaNova PLC Files 10-Q for Period Ending March 31, 2024 — 10-Q · 2024-05-03T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC (LIVN) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. LivaNova PLC filed a 10-Q report for the quarterly period ended March 31, 2024.
• LivaNova PLC Files 8-K on Financials and Operations — 8-K · 2024-05-01T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on May 1, 2024, reporting on its results of operations, financial condition, and providing Regulation FD disclosures. The filing also
• LivaNova PLC Announces 2024 Annual General Meeting on June 11 — DEF 14A · 2024-04-26T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC (LIVN) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. LivaNova PLC will hold its 2024 Annual General Meeting (AGM) on Tuesday, J
• SC 13G Filing — SC 13G · 2024-04-17T00:00:00.000Z [neutral]
• LivaNova PLC Files 8-K: Material Agreement, Equity Sales — 8-K · 2024-03-08T00:00:00.000Z [neutral] Risk: medium
  On March 8, 2024, LivaNova PLC entered into a material definitive agreement, likely related to financing or operations, as indicated by the filing of an 8-K. Th
• LivaNova Acquires Tandem Diabetes Care for $1.3B — 8-K · 2024-03-06T00:00:00.000Z [bullish] Risk: medium
  LivaNova PLC announced on March 5, 2024, that it has completed the acquisition of all outstanding shares of Tandem Diabetes Care, Inc. for $13.00 per share in c
• LivaNova PLC Files 8-K — 8-K · 2024-03-04T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on March 4, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does not contain
• LivaNova PLC Files 2023 Annual Report on Form 10-K — 10-K · 2024-02-29T00:00:00.000Z [neutral] Risk: medium
  LivaNova PLC (LIVN) filed a Annual Report (10-K) with the SEC on February 29, 2024. LivaNova PLC filed its 2023 Form 10-K on February 29, 2024. The filing cover
• LivaNova PLC Files 8-K on Financial Condition and Operations — 8-K · 2024-02-21T00:00:00.000Z [neutral] Risk: low
  LivaNova PLC filed an 8-K on February 21, 2024, reporting on its results of operations and financial condition. The filing indicates that the company, incorpora
• PRIMECAP Management Co. Reports 5.57M LivaNova Shares — SC 13G/A · 2024-02-12T00:00:00.000Z [neutral] Risk: low
  PRIMECAP Management Company, a Pasadena, CA-based investment firm, filed an amended SC 13G/A on February 12, 2024, disclosing its beneficial ownership in LivaNo
• LivaNova PLC Updates Corporate Info, Confirms NASDAQ Listing — 8-K · 2024-02-05T00:00:00.000Z [neutral]
  LivaNova PLC filed an 8-K on February 5, 2024, reporting an event that occurred on February 1, 2024. This filing indicates a routine update to their corporate i
• BlackRock Amends LivaNova PLC Stake (SC 13G/A, 10th Amendment) — SC 13G/A · 2024-01-23T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 23, 2024, disclosing its ownership in LivaNova PLC as of December 31, 2023. This amendment, the 10th for Bla
• LivaNova PLC Files Routine 8-K, No Material Changes Reported — 8-K · 2024-01-08T00:00:00.000Z [neutral]
  LivaNova PLC, a medical device company, filed an 8-K on January 8, 2024, reporting an event that occurred on January 5, 2024. This filing is a routine report in